All team members
LL.M. University of Chicago
Marco is a highly experienced lawyer, skilled in handling national and international patent infringement cases, border seizure proceedings and conflicts arising from technology-related contracts. He advises companies in the areas of technical IP rights, technology transfers and also on a wide variety of contractual matters. He acts in an advisory capacity on questions relating to design rights, competition law, employee inventions and trade secrets.
Marco has headed Maiwald’s legal department since 2017. He lectures in intellectual property rights at the University of Dresden and is associate lecturer in patent and international contract law at the University of Marburg.
“very experienced in pharma litigation, extraordinary knowledge of SPCs”
– JUVE Patent, 2021
"Marco Stief, who 'brings great technical understanding and a very outcome-oriented and practical approach to any project, is always very responsive and has a brilliant strategic mind'. 'He is very convincing in court and always thinks one step ahead.'"
– IAM Patent 1000, 2020
"Heading up the legal department is seasoned attorney at law Marco Stief, who is equally proficient in litigation and licensing scenarios. Recent credits include acting in preliminary injunction proceedings on behalf of Fresenius against Eli Lilly."
– IAM Patent 1000, 2021
"Stief, der das Rechtsanwaltsteam leitet, gilt in der Branche als ausgewiesener Experte für Lizenzen u. Fragen rund um Verlängerungspatente für Arzneien (SPCs)."
– JUVE, 2021
"With Marco Stief you can tell that he knows the industry through and through. In addition to excellent legal knowledge, he has a quick technical understanding of our very different products. What is decisive for us, however, is that he always keeps an eye on the long-term consequences and knows the market and related areas of law very well. This enables him to develop creative solutions and to discuss possible solutions and strategies directly at management level."
– Legal 500 EMEA, 2022
"Marco Stief stands out among peers for his in-depth patent knowledge and clear focus on pharmaceutical-related IP matters."
– Who´s Who Legal, 2022
“'Excellent litigator' Marco Stief is described as 'experienced and knowledgeable' by peers for his work in the patent arena."
– Who's Who Legal, 2022
"Marco Stief is one of the leading individuals in Germany for patent strategy, particularly in the pharmaceutical field. Marco maintains one of the best Supplementary Protection Certificate practices in the country and is considered a thought leader in this space."
– IAM 300, 2022
"Marco Stief is highlighted by market sources as 'a trusted adviser and excellent litigator' who 'knows all the tricks' and has 'great experience in particular in pharma-related matters'"
– Who's Who Legal, 2023
Pharmaceutical, Biological and Chemical Patents, C.H.BECK, 2019 (gemeinsam hrsg. mit Maximilian Haedicke und Dirk Bühler)
Vertragshandbuch Pharma und Life Sciences, C.H.BECK, 2. Auflage, 2019 (gemeinsam hrsg. mit Boris Bromm)
Supplementary Protection Certificates (SPC), C.H.BECK, Stief/Bühler (published together), 2016
Handbuch des Patentrechts, Haedicke/Timmann (Hrsg.), C.H.BECK, 2012 (together with Johannes W. Bukow et al.)
Praktische Erfahrung mit der Grenzbeschlagnahme nach VO (EG) Nr. 1383/2003, in: Festschrift für Ulf Doepner, Reese/Hufnagel/Lensing-Kramer (Hrsg.), C.H.BECK, 2008 (gemeinsam mit Peter Chrocziel)